Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar SmallPimpin (94.30) Submitted: 8/5/2009 2:43:46 PM : Outperform Start Price: $31.24 ONXX Score: +17.47

Mmm...pharmaceuticals...

Featured Broker Partners


Advertisement